Cargando…

TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p

Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD), where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression through aberrant protein–protein interactions mediated via i...

Descripción completa

Detalles Bibliográficos
Autores principales: Berrout, Jonathan, Kyriakopoulou, Eleni, Moparthi, Lavanya, Hogea, Alexandra S., Berrout, Liza, Ivan, Cristina, Lorger, Mihaela, Boyle, John, Peers, Chris, Muench, Stephen, Gomez, Jacobo Elies, Hu, Xin, Hurst, Carolyn, Hall, Thomas, Umamaheswaran, Sujanitha, Wesley, Laura, Gagea, Mihai, Shires, Michael, Manfield, Iain, Knowles, Margaret A., Davies, Simon, Suhling, Klaus, Gonzalez, Yurema Teijeiro, Carragher, Neil, Macleod, Kenneth, Abbott, N. Joan, Calin, George A., Gamper, Nikita, Zygmunt, Peter M., Timsah, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643494/
https://www.ncbi.nlm.nih.gov/pubmed/29038531
http://dx.doi.org/10.1038/s41467-017-00983-w
_version_ 1783271542266789888
author Berrout, Jonathan
Kyriakopoulou, Eleni
Moparthi, Lavanya
Hogea, Alexandra S.
Berrout, Liza
Ivan, Cristina
Lorger, Mihaela
Boyle, John
Peers, Chris
Muench, Stephen
Gomez, Jacobo Elies
Hu, Xin
Hurst, Carolyn
Hall, Thomas
Umamaheswaran, Sujanitha
Wesley, Laura
Gagea, Mihai
Shires, Michael
Manfield, Iain
Knowles, Margaret A.
Davies, Simon
Suhling, Klaus
Gonzalez, Yurema Teijeiro
Carragher, Neil
Macleod, Kenneth
Abbott, N. Joan
Calin, George A.
Gamper, Nikita
Zygmunt, Peter M.
Timsah, Zahra
author_facet Berrout, Jonathan
Kyriakopoulou, Eleni
Moparthi, Lavanya
Hogea, Alexandra S.
Berrout, Liza
Ivan, Cristina
Lorger, Mihaela
Boyle, John
Peers, Chris
Muench, Stephen
Gomez, Jacobo Elies
Hu, Xin
Hurst, Carolyn
Hall, Thomas
Umamaheswaran, Sujanitha
Wesley, Laura
Gagea, Mihai
Shires, Michael
Manfield, Iain
Knowles, Margaret A.
Davies, Simon
Suhling, Klaus
Gonzalez, Yurema Teijeiro
Carragher, Neil
Macleod, Kenneth
Abbott, N. Joan
Calin, George A.
Gamper, Nikita
Zygmunt, Peter M.
Timsah, Zahra
author_sort Berrout, Jonathan
collection PubMed
description Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD), where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression through aberrant protein–protein interactions mediated via its C-terminal proline-rich motif. Here we report that the N-terminal ankyrin repeats of TRPA1 directly bind to the C-terminal proline-rich motif of FGFR2 inducing the constitutive activation of the receptor, thereby prompting LUAD progression and metastasis. Furthermore, we show that upon metastasis to the brain, TRPA1 gets depleted, an effect triggered by the transfer of TRPA1-targeting exosomal microRNA (miRNA-142-3p) from brain astrocytes to cancer cells. This downregulation, in turn, inhibits TRPA1-mediated activation of FGFR2, hindering the metastatic process. Our study reveals a direct binding event and characterizes the role of TRPA1 ankyrin repeats in regulating FGFR2-driven oncogenic process; a mechanism that is hindered by miRNA-142-3p.
format Online
Article
Text
id pubmed-5643494
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56434942017-10-18 TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p Berrout, Jonathan Kyriakopoulou, Eleni Moparthi, Lavanya Hogea, Alexandra S. Berrout, Liza Ivan, Cristina Lorger, Mihaela Boyle, John Peers, Chris Muench, Stephen Gomez, Jacobo Elies Hu, Xin Hurst, Carolyn Hall, Thomas Umamaheswaran, Sujanitha Wesley, Laura Gagea, Mihai Shires, Michael Manfield, Iain Knowles, Margaret A. Davies, Simon Suhling, Klaus Gonzalez, Yurema Teijeiro Carragher, Neil Macleod, Kenneth Abbott, N. Joan Calin, George A. Gamper, Nikita Zygmunt, Peter M. Timsah, Zahra Nat Commun Article Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD), where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression through aberrant protein–protein interactions mediated via its C-terminal proline-rich motif. Here we report that the N-terminal ankyrin repeats of TRPA1 directly bind to the C-terminal proline-rich motif of FGFR2 inducing the constitutive activation of the receptor, thereby prompting LUAD progression and metastasis. Furthermore, we show that upon metastasis to the brain, TRPA1 gets depleted, an effect triggered by the transfer of TRPA1-targeting exosomal microRNA (miRNA-142-3p) from brain astrocytes to cancer cells. This downregulation, in turn, inhibits TRPA1-mediated activation of FGFR2, hindering the metastatic process. Our study reveals a direct binding event and characterizes the role of TRPA1 ankyrin repeats in regulating FGFR2-driven oncogenic process; a mechanism that is hindered by miRNA-142-3p. Nature Publishing Group UK 2017-10-16 /pmc/articles/PMC5643494/ /pubmed/29038531 http://dx.doi.org/10.1038/s41467-017-00983-w Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Berrout, Jonathan
Kyriakopoulou, Eleni
Moparthi, Lavanya
Hogea, Alexandra S.
Berrout, Liza
Ivan, Cristina
Lorger, Mihaela
Boyle, John
Peers, Chris
Muench, Stephen
Gomez, Jacobo Elies
Hu, Xin
Hurst, Carolyn
Hall, Thomas
Umamaheswaran, Sujanitha
Wesley, Laura
Gagea, Mihai
Shires, Michael
Manfield, Iain
Knowles, Margaret A.
Davies, Simon
Suhling, Klaus
Gonzalez, Yurema Teijeiro
Carragher, Neil
Macleod, Kenneth
Abbott, N. Joan
Calin, George A.
Gamper, Nikita
Zygmunt, Peter M.
Timsah, Zahra
TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
title TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
title_full TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
title_fullStr TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
title_full_unstemmed TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
title_short TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
title_sort trpa1–fgfr2 binding event is a regulatory oncogenic driver modulated by mirna-142-3p
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643494/
https://www.ncbi.nlm.nih.gov/pubmed/29038531
http://dx.doi.org/10.1038/s41467-017-00983-w
work_keys_str_mv AT berroutjonathan trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT kyriakopouloueleni trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT moparthilavanya trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT hogeaalexandras trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT berroutliza trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT ivancristina trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT lorgermihaela trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT boylejohn trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT peerschris trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT muenchstephen trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT gomezjacoboelies trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT huxin trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT hurstcarolyn trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT hallthomas trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT umamaheswaransujanitha trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT wesleylaura trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT gageamihai trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT shiresmichael trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT manfieldiain trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT knowlesmargareta trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT daviessimon trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT suhlingklaus trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT gonzalezyuremateijeiro trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT carragherneil trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT macleodkenneth trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT abbottnjoan trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT calingeorgea trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT gampernikita trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT zygmuntpeterm trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p
AT timsahzahra trpa1fgfr2bindingeventisaregulatoryoncogenicdrivermodulatedbymirna1423p